ICD-9-CM Coordination and Maintenance Committee Meeting, 51985-51986 [2011-21167]

Download as PDF 51985 Federal Register / Vol. 76, No. 161 / Friday, August 19, 2011 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Form name Tobacco Control Programs ............................. Quitline Promotion Activities Data ................. Intake Data for QL Clients ............................. Intake Data for Web Services Clients ............ Follow-up Survey for QL Clients .................... Follow-up Survey for Web Clients ................. Quitline Clients ................................................ Web Services Clients ...................................... Dated: August 15, 2011. Daniel Holcomb, Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. 2011–21204 Filed 8–18–11; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review jlentini on DSK4TPTVN1PROD with NOTICES The meeting announced below concerns Special Interest Project (SIP): Systematic Review of Effective Community-based Interventions of Clinical Preventive Services for Older Adults, SIP11–045, initial review. Correction: This notice was published in the Federal Register on August 11, 2011, Volume 76, Number 155, Page 49771. The time for the aforementioned meeting has been changed to the following. Time 12 p.m.–2 p.m., August 31, 2011 (Closed). Contact Person for More Information: Robin Hamre, M.P.H., R.D., Scientific Review Officer, Extramural Research Program Office, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway, NE., Mailstop K–92, Atlanta, Georgia 30341, RWH9@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elizabeth Millington, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2011–21217 Filed 8–18–11; 8:45 am] BILLING CODE 4163–18–P 18:32 Aug 18, 2011 Centers for Disease Control and Prevention ICD–9–CM Coordination and Maintenance Committee Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES VerDate Mar<15>2010 DEPARTMENT OF HEALTH AND HUMAN SERVICES Jkt 223001 National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting. Name: ICD–9–CM Coordination and Maintenance Committee meeting. Time and Date: 9 a.m.–5:30 p.m., September 14, 2011. Place: Centers for Medicare and Medicaid Services (CMS) Auditorium, 7500 Security Boulevard, Baltimore, Maryland 21244. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 240 people. Security Considerations: Due to increased security requirements CMS has instituted stringent procedures for entrance into the building by nongovernment employees. Attendees will need to present valid government-issued picture identification, and sign-in at the security desk upon entering the building. Attendees who wish to attend a specific ICD–9–CM C&M meeting on September 14, 2011, must submit their name and organization by September 9, 2011, for inclusion on the visitor list. This visitor list will be maintained at the front desk of the CMS building and used by the guards to admit visitors to the meeting. Participants who attended previous ICD–9–CM C&M meetings will no longer be automatically added to the visitor list. You must request inclusion of your name prior to each meeting you attend. Please register to attend the meeting on-line at: https://www.cms.hhs.gov/ apps/events/. Please contact Mady Hue (410–786–4510 or Marilu.hue@cms.hhs.gov), for questions about the registration process. Purpose: The ICD–9–CM Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Number of responses per respondent Average burden per response (in hr) 4 4 4 1 1 10/60 15/60 15/60 15/60 15/60 50 2 2 2,000 2,000 International Classification of Diseases, Ninth-Revision, Clinical Modification. Matters To Be Discussed: Agenda items include: September 14, 2011 ICD–10 Updates 2012 ICD–10–PCS. 2012 ICD–10–PCS GEM and Reimbursement Map Updates. ICD–10–PCS Official Coding Guidelines. ICD–10 MS–DRGs. ICD–9–CM Procedure Topics Electromagnetic Tip Tracked Sensor devices used in lung bronchoscopy and lung biopsy procedures. Extracorporeal Heart and Lung Assist System, including Membrane Oxygenation, CO2 Removal. ICD–10–PCS Topics Implantable meshes. ICD–10–CM Diagnosis Topics Aggressive periodontitis. Chronic Fatigue Syndrome. Chronic periodontitis. Gingival recession. Agenda items are subject to change as priorities dictate. Note: CMS and NCHS will no longer provide paper copies of handouts for the meeting. Electronic copies of all meeting materials will be posted on the CMS and NCHS websites prior to the meeting at http: //www.cms.hhs.gov/ ICD9ProviderDiagnosticCodes/ 03_meetings.asp#TopOfPage and https:// www.cdc.gov/nchs/icd/ icd9cm_maintenance.htm. Contact Persons for Additional Information: Donna Pickett, Medical Systems Administrator, Classifications and Public Health Data Standards Staff, NCHS, 3311 Toledo Road, Room 2337, Hyattsville, Maryland 20782, e-mail dfp4@cdc.gov, telephone 301–458–4434 (diagnosis); Mady Hue, Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security Boulevard, Baltimore, Maryland 21244, e-mail marilu.hue@cms.hhs.gov, telephone 410–786–4510 (procedures). The Director, Management Analysis and Services Office, has been delegated E:\FR\FM\19AUN1.SGM 19AUN1 51986 Federal Register / Vol. 76, No. 161 / Friday, August 19, 2011 / Notices the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Dated: August 10, 2011. Elizabeth Millington, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. BILLING CODE 4160–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families President’s Committee for People With Intellectual Disabilities (PCPID); Notice of Meeting President’s Committee for People with Intellectual Disabilities (PCPID), Administration for Children and Families, HHS. ACTION: Notice of meeting. AGENCY: Monday, September 26, 2011, from 8:30 a.m. to 5 p.m. EST; and Tuesday, September 27, 2011, from 9 a.m. to 5 p.m. EST. The meeting will be open to the public. ADDRESSES: The meeting will be held in Conference Room 505–A of the Hubert H. Humphrey Building, U.S. Department of Health and Human Services, 200 Independence Avenue, SW., Washington, DC 20201. Individuals who would like to participate via conference call may do so by dialing 800–857–4846, pass code: 14201. Individuals who will need accommodations for a disability in order to attend the meeting (e.g., sign language interpreting services, assistive listening devices, materials in alternative format such as large print or Braille) should notify Genevieve Swift, PCPID Executive Administrative Assistant, via e-mail at Edith.Swift@acf.hhs.gov, or via telephone at 202–619–0634, no later than Monday, September 19, 2011. PCPID will attempt to meet requests for accommodations made after that date, but cannot guarantee ability to grant requests received after this deadline. All meeting sites are barrier free. Agenda: Committee members will discuss preparation of the PCPID 2011 Report to the President, including its content and format, and related data collection and analysis required to complete the writing of the Report. jlentini on DSK4TPTVN1PROD with NOTICES VerDate Mar<15>2010 18:32 Aug 18, 2011 Jkt 223001 PCPID acts in an advisory capacity to the President and the Secretary of Health and Human Services, through the Administration on Developmental Disabilities, on a broad range of topics relating to programs, services and supports for persons with intellectual disabilities. The PCPID Executive Order stipulates that the Committee shall: (1) Provide such advice concerning intellectual disabilities as the President or the Secretary of Health and Human Services may request; and (2) provide advice to the President concerning the following for people with intellectual disabilities: (A) Expansion of educational opportunities; (B) promotion of homeownership; (C) assurance of workplace integration; (D) improvement of transportation options; (E) expansion of full access to community living; and (F) increasing access to assistive and universally designed technologies. SUPPLEMENTARY INFORMATION: [FR Doc. 2011–21167 Filed 8–18–11; 8:45 am] DATES: Additional Information: For further information, please contact Laverdia Taylor Roach, Senior Advisor, President’s Committee for People with Intellectual Disabilities, The Aerospace Center, Second Floor West, 370 L’Enfant Promenade, SW., Washington, DC 20447. Telephone: 202–619–0634. Fax: 202–205–9519. E-mail: LRoach@acf.hhs.gov. Dated: August 12, 2011. Jamie Kendall, Deputy Commissioner, Administration on Developmental Disabilities. [FR Doc. 2011–21240 Filed 8–18–11; 8:45 am] BILLING CODE 4184–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0410] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Notification for a New Dietary Ingredient AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995 (the PRA). SUMMARY: PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 Fax written comments on the collection of information by September 19, 2011. ADDRESSES: To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202–395–7285, or e-mailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910–0330. Also include the FDA docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50–400B, Rockville, MD 20850, 301– 796–3793. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. DATES: Premarket Notification for a New Dietary Ingredient—21 CFR 190.6— (OMB Control Number 0910–0330)— Extension Section 413(a) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 350b(a)) provides that at least 75 days before the introduction or delivery for introduction into interstate commerce of a dietary supplement that contains a new dietary ingredient (NDI), a manufacturer or distributor of an NDI, or of the dietary supplement that contains the NDI, is to submit to FDA (as delegate for the Secretary of Health and Human Services) the information which is the basis on which the manufacturer or distributor has concluded that a dietary supplement containing an NDI will reasonably be expected to be safe. Section 190.6 (21 CFR 190.6) implements this statutory provision. Section 190.6(a) requires each manufacturer or distributor of a dietary supplement containing an NDI, or of an NDI, to submit to the Office of Nutrition, Labeling, and Dietary Supplements notification of the basis for their conclusion that said supplement or ingredient will reasonably be expected to be safe. Section 190.6(b) requires that the notification include the following: (1) The complete name and address of the manufacturer or distributor, (2) the name of the NDI, (3) a description of the dietary supplements that contain the NDI, and (4) the history of use or other evidence of safety establishing that the dietary ingredient will reasonably be expected to be safe. E:\FR\FM\19AUN1.SGM 19AUN1

Agencies

[Federal Register Volume 76, Number 161 (Friday, August 19, 2011)]
[Notices]
[Pages 51985-51986]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-21167]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

ICD-9-CM Coordination and Maintenance Committee Meeting

National Center for Health Statistics (NCHS), Classifications and
Public Health Data Standards Staff, announces the following meeting.
Name: ICD-9-CM Coordination and Maintenance Committee meeting.
Time and Date: 9 a.m.-5:30 p.m., September 14, 2011.
Place: Centers for Medicare and Medicaid Services (CMS) Auditorium,
7500 Security Boulevard, Baltimore, Maryland 21244.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 240 people.
Security Considerations: Due to increased security requirements CMS
has instituted stringent procedures for entrance into the building by
non-government employees. Attendees will need to present valid
government-issued picture identification, and sign-in at the security
desk upon entering the building. Attendees who wish to attend a
specific ICD-9-CM C&M meeting on September 14, 2011, must submit their
name and organization by September 9, 2011, for inclusion on the
visitor list. This visitor list will be maintained at the front desk of
the CMS building and used by the guards to admit visitors to the
meeting.
Participants who attended previous ICD-9-CM C&M meetings will no
longer be automatically added to the visitor list. You must request
inclusion of your name prior to each meeting you attend.
Please register to attend the meeting on-line at: https://www.cms.hhs.gov/apps/events/. Please contact Mady Hue (410-786-4510 or
Marilu.hue@cms.hhs.gov), for questions about the registration process.
Purpose: The ICD-9-CM Coordination and Maintenance (C&M) Committee
is a public forum for the presentation of proposed modifications to the
International Classification of Diseases, Ninth-Revision, Clinical
Modification.
Matters To Be Discussed: Agenda items include:

September 14, 2011

ICD-10 Updates

2012 ICD-10-PCS.
2012 ICD-10-PCS GEM and Reimbursement Map Updates.
ICD-10-PCS Official Coding Guidelines.
ICD-10 MS-DRGs.

ICD-9-CM Procedure Topics

Electromagnetic Tip Tracked Sensor devices used in lung
bronchoscopy and lung biopsy procedures.
Extracorporeal Heart and Lung Assist System, including Membrane
Oxygenation, CO2 Removal.

ICD-10-PCS Topics

Implantable meshes.

ICD-10-CM Diagnosis Topics

Aggressive periodontitis.
Chronic Fatigue Syndrome.
Chronic periodontitis.
Gingival recession.
Agenda items are subject to change as priorities dictate.

Note: CMS and NCHS will no longer provide paper copies of
handouts for the meeting. Electronic copies of all meeting materials
will be posted on the CMS and NCHS websites prior to the meeting at
https://www.cms.hhs.gov/ICD9ProviderDiagnosticCodes/03_meetings.asp#TopOfPage and https://www.cdc.gov/nchs/icd/icd9cm_maintenance.htm.

Contact Persons for Additional Information: Donna Pickett, Medical
Systems Administrator, Classifications and Public Health Data Standards
Staff, NCHS, 3311 Toledo Road, Room 2337, Hyattsville, Maryland 20782,
e-mail dfp4@cdc.gov, telephone 301-458-4434 (diagnosis); Mady Hue,
Health Insurance Specialist, Division of Acute Care, CMS, 7500 Security
Boulevard, Baltimore, Maryland 21244, e-mail marilu.hue@cms.hhs.gov,
telephone 410-786-4510 (procedures).
The Director, Management Analysis and Services Office, has been
delegated

[[Page 51986]]

the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.

Dated: August 10, 2011.
Elizabeth Millington,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2011-21167 Filed 8-18-11; 8:45 am]
BILLING CODE 4160-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.